Oruka Therapeutics, Inc. (NASDAQ:ORKA) Given Average Rating of "Moderate Buy" by Analysts
Oruka Therapeutics, Inc. (NASDAQ:ORKA - Get Free Report) has been given an average recommendation of "Moderate Buy" by the eight research firms that are presently covering the stock, Marketbeat.com...